Clinical Trial Update: Improving Varenicline Adherence and Outcomes in Homeless Smokers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating varenicline adherence and smoking cessation outcomes in homeless smokers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: University of Minnesota | Conditions: Tobacco Use Cessation | Phase 3 | Status: COMPLETED